HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helen of Troy

This article was originally published in The Rose Sheet

Executive Summary

Personal care sales rose 4.8% to $105.3 mil. for the first quarter (ended May 31), the firm reported during a July 10 analyst call. Helen of Troy attributed the performance to new product offerings with higher average unit prices, expanded offerings with current customers, the addition of new domestic customers and "continued growth" in the firm's Latin American territories. Sales also benefited from a 5.9% increase in the grooming segment, which includes hair and skin care lines Brut,Sea Breeze,Vitalis and Condition 3-in-1. Helen of Troy's net sales rose 2.4% to $130.4 mil., while net earnings dropped 36.4% to $6.7 mil. or $0.21 per fully diluted share. Regarding the outlook of personal care, the firm notes early indications of the retail sell-through of higher end personal care products in the mass channel are "encouraging"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014071

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel